Michel Tremblay awarded RSC’s McLaughlin Medal

Live 2017

Source: McGill Reporter story by Amanda Testani

Earlier today, the Royal Society of Canada (RSC) announced that Professor Michel L. Tremblay (Department of Biochemistry and Goodman Cancer Research Centre) has been awarded the McLaughlin Medal for important research of sustained excellence in medical science. Recognized for his leading-edge work on the role and function of tyrosine phosphatases in the development of cancer, Professor Tremblay is among the twelve Canadian researchers honoured with an RSC medal or award this year.

The RSC first established the prestigious McLaughlin Medal in 1978 with an endowment from the R. Samuel McLaughlin Foundation. Awarded annually and bestowed upon candidates with distinguished achievements in any branch of medical sciences in Canada, Professor Tremblay is the third McGill researcher to win the medal since 2013, joining previous medal winners Professor Philippe Gros and Professor Nahum Sonenberg.

“Professor Michel L. Tremblay’s research contributions have changed the way the world understands a broad spectrum of diseases and conditions affecting Canadians and people worldwide,” said Professor Martha Crago, Vice-Principal (Research and Innovation). “I want to express my sincere congratulations to Professor Tremblay on this achievement and thank the Royal Society of Canada for awarding him the prestigious McLaughlin Medal.”

Professor Tremblay investigates the role of protein tyrosine phosphatases (PTPases) in the development of cancer. PTPases are a group of enzymes that regulate various signaling pathways in cells, a process that plays an essential role in many biological and pathological processes. PTPases have been implicated in a variety of cellular processes such as cell growth and differentiation. As well as diverse cancers, his research has also successfully shown that PTPases play key roles in other health conditions such as diabetes, obesity, spinal cord injury and infectious diseases. His research will lead to the development of new treatments for a broad range of human diseases.

Professor Tremblay was the first director of the Rosalind and Morris Goodman Cancer Research Centre where his laboratory is located. He was recruited to McGill in March 1992 and trained and mentored over 65 researchers, students, postdoctoral fellows and supporting staff in the biology and function of the protein tyrosine phosphatases.

Congratulations Dr. Tremblay!

Read the Royal Society of Canada announcement

September 19, 2017

Be Sociable, Share!

Speak Your Mind

This blog is kept spam free by WP-SpamFree.